Skip to main content
Clinical Trials/NCT01219504
NCT01219504
Completed
Not Applicable

Evaluation of the Impact of Embryo Biopsy on the Reproductive Potential of Embryos Undergoing IVF

Reproductive Medicine Associates of New Jersey3 sites in 1 country200 target enrollmentApril 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Each Patient is Both Case and Control
Sponsor
Reproductive Medicine Associates of New Jersey
Enrollment
200
Locations
3
Primary Endpoint
Impact of biopsy on delivery
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

To assess the impact of embryo biopsy on the reproductive potential of human embryos.

Detailed Description

This study will recruit patients from the NY/NJ/CT/eastern PA area only. All patients will undergo an in vitro fertilization (IVF) cycle with hormonal stimulation and an egg retrieval procedure as deemed appropriate for their diagnosis. Following biopsy, the embryos will be transferred. There will be no delay in the time of transfer as no cells will be analyzed prior to transfer. On day 3 or day 5 of embryo development, all patients will undergo a two (2) embryo transfer. The embryos selected for transfer will be the 2 morphologically best of the embryo cohort. Once selected for transfer, the embryos will be randomized so that one will be biopsied and the other will be transferred without undergoing biopsy. The embryo randomized to biopsy will have a single cell biopsied. Following delivery, buccal swabs will be collected from infants.

Registry
clinicaltrials.gov
Start Date
April 2008
End Date
September 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Maximum of one prior failed IVF treatment cycle
  • Female partner less than 35 years of age
  • Normal day 3 FSH level (\<10 miu/mL)
  • Total basal antral follicle count greater than or equal to 12
  • Male partner with greater than 100,000 total motile spermatozoa and at least 1% normal forms
  • Body mass index (BMI) \< or = 32
  • Normal uterine cavity

Exclusion Criteria

  • Diagnosis of chronic anovulation secondary to polycystic ovarian disease
  • Diagnosis of endometrial insufficiency
  • Clinical indication for pre-implantation genetic diagnosis (PGD) (undergoing IVF with PGD to rule out a known genetic defect)
  • Use of testicular aspiration or biopsy procedures to obtain sperm

Outcomes

Primary Outcomes

Impact of biopsy on delivery

Time Frame: 1 year

Impact of the biopsy on pregnancy resulting in delivery

Impact of biopsy on pregnancy

Time Frame: 1 year

Impact of the biopsy of the embryo on whether a pregnancy is obtained

Study Sites (3)

Loading locations...

Similar Trials